SteriLance Launches Innovative Cap-Free Blood Sampling Device in Spain

SteriLance Medical's Breakthrough Launch in Spain

SteriLance Medical, a renowned leader in the field of personal blood sampling solutions, has made its notable entrance into the European market with the launch of its revolutionary Onestep™ lancing device and its companion product, the SoftSense™ lancets. This debut takes place in Spain, a strategic move aimed at addressing the needs of millions of individuals in Europe managing chronic conditions like diabetes.

A New Approach to Blood Sampling

The Onestep device is touted as the world’s first cap-free, four-step lancing pen, innovatively designed to keep the needle concealed at all times. Powered by the patented Total Path Control™ (TPC) Vertical-Drive technology, it enables users to collect blood samples with minimal discomfort. What sets Onestep apart is its significantly streamlined operation, which reduces the preparation steps by about 50%. Users can appreciate several key features that make this device unique:

1. Simplified Needle Loading: The lancet can be loaded and removed in one easy motion—by simply inserting the SoftSense lancet and twisting off the protective cap without needing to detach the pen cap.
2. Efficient Workflow: The four-step process—Insert, Twist, Push, Eject—translates to approximately 70% fewer actions compared to traditional lancing devices.
3. Pain Reduction: The TPC Vertical-Drive mechanism guides the needle directly and steadily, reducing vibrations and potential tissue trauma for a nearly painless experience.
4. Concealed Design: The permanent concealment of the needle helps alleviate patients' fears associated with needles, significantly decreasing the probability of accidental injuries.

In a study involving 30 frequent users, an impressive 92% reported experiencing little to no pain during use, while 87% felt more secure knowing they never had to see the needle.

The Diabetes Landscape in Spain

With approximately 5.1 million adults living with diabetes in Spain, which represents one of the highest prevalence rates in Europe, the launch of the Onestep device comes at a crucial time. Pain-free and easy-to-use devices like the Onestep can play a pivotal role in improving adherence to daily self-monitoring, which is essential for effective diabetes management.

Availability and Future Expansion

Starting immediately, the Onestep and SoftSense products are available in Spain through select pharmacies and e-commerce partners. SteriLance has plans for a broader retail rollout across additional EU markets in the coming months.

Both Onestep and SoftSense are CE-MDR and ISO 13485 certified, demonstrating their compliance with regulatory standards and suitability for frequent home use for capillary sampling.

For further insights and information about the Onestep device and its features, individuals can visit the official SteriLance website at SteriLance Onestep.

For media or distribution inquiries, please contact [email protected]